Literature DB >> 14632190

Germline fumarate hydratase mutations in families with multiple cutaneous and uterine leiomyomata.

Amalia Martinez-Mir1, Benjamin Glaser, Gary S Chuang, Liran Horev, Arie Waldman, Danielle E Engler, Derek Gordon, Lynda J Spelman, Ioannis Hatzibougias, Jack Green, Angela M Christiano, Abraham Zlotogorski.   

Abstract

Germline mutations in the fumarate hydratase gene (FH) predispose to multiple cutaneous and uterine leiomyoma syndrome (MCL) and MCL associated with renal cell cancer. MCL is inherited in an autosomal dominant pattern, manifesting as skin leiomyoma and uterine fibroids in affected individuals. Fumarate hydratase, a component of the tricarboxylic acid cycle, acts as a tumor suppressor gene in the development of cutaneous and uterine leiomyoma and renal cell cancer in this syndrome. Here we report the clinical and mutational analysis of five families with MCL, with the identification of five new mutations affecting highly conserved residues of the FH protein. These results provide further evidence for the role of the FH gene in the pathogenesis of MCL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14632190     DOI: 10.1046/j.1523-1747.2003.12499.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  17 in total

1.  [Keratosis palmoplantaris papulosa].

Authors:  C Mühlhoff; M Megahed
Journal:  Hautarzt       Date:  2012-05       Impact factor: 0.751

2.  Increased risk of cancer in patients with fumarate hydratase germline mutation.

Authors:  H J Lehtonen; M Kiuru; S K Ylisaukko-Oja; R Salovaara; R Herva; P A Koivisto; O Vierimaa; K Aittomäki; E Pukkala; V Launonen; L A Aaltonen
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

Review 3.  Factors affecting statistical power in the detection of genetic association.

Authors:  Derek Gordon; Stephen J Finch
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

4.  Melanoma and basal cell carcinoma in the hereditary leiomyomatosis and renal cell cancer syndrome. An expansion of the oncologic spectrum.

Authors:  Lacy L Sommer; Rhonda E Schnur; Warren R Heymann
Journal:  J Dermatol Case Rep       Date:  2016-11-30

5.  No evidence for the role of somatic mutations and promoter hypermethylation of FH gene in the tumorigenesis of nonsyndromic uterine leiomyomas.

Authors:  Sireesha Vaidya; Noor Ahmad Shaik; Madhavi Latha; Srinivas Chava; Khaliq Mohiuddin; Annapurna Yalla; Kaipa Prabhakar Rao; Vijaya Lakshmi Kodati; Qurratulain Hasan
Journal:  Tumour Biol       Date:  2012-04-20

6.  Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.

Authors:  Laveta Stewart; Gladys M Glenn; Pamela Stratton; Alisa M Goldstein; Maria J Merino; Margaret A Tucker; W Marston Linehan; Jorge R Toro
Journal:  Arch Dermatol       Date:  2008-12

Review 7.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

8.  Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.

Authors:  Julian Sanz-Ortega; Cathy Vocke; Pamela Stratton; William Marston Linehan; Maria J Merino
Journal:  Am J Surg Pathol       Date:  2013-01       Impact factor: 6.394

9.  Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening.

Authors:  Lisa Siegler; Ramona Erber; Stefanie Burghaus; Tobias Brodkorb; David Wachter; Nafisa Wilkinson; James Bolton; Helen Stringfellow; Florian Haller; Matthias W Beckmann; Arndt Hartmann; Abbas Agaimy
Journal:  Virchows Arch       Date:  2018-01-13       Impact factor: 4.064

10.  Multiple cutaneous and uterine leiomyomatosis syndrome: a review.

Authors:  Sonal Choudhary; Michael McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.